Triazolo[1,5-A]Pyrimidines as Novel Cdk2 Inhibitors: Protein Structure-Guided Design and Sar.
Richardson, C.M., Williamson, D.S., Parratt, M.J., Borgognoni, J., Cansfield, A.D., Dokurno, P., Francis, G.L., Howes, R., Moore, J.D., Murray, J.B., Robertson, A., Surgenor, A.E., Torrance, C.J.(2006) Bioorg Med Chem Lett 16: 1353
- PubMed: 16325401 
- DOI: https://doi.org/10.1016/j.bmcl.2005.11.048
- Primary Citation of Related Structures:  
2C68, 2C69, 2C6I, 2C6K, 2C6L, 2C6M, 2C6O, 2C6T - PubMed Abstract: 
Crystallographic and modelling data, in conjunction with a medicinal chemistry template-hopping approach, led to the identification of a series of novel and potent inhibitors of human cyclin-dependent kinase 2 (CDK2), with selectivity over glycogen synthase kinase-3beta (GSK-3beta) ...